U.S. Industrial REITs Stock News

Wondering whether Global Net Lease at about US$9.20 is offering fair value or an opportunity? This article walks through what the current price may be implying. The stock is up 0.9% over the last week, has slipped 3.1% over the last month, yet sits 4.3% higher year to date and 26.3% higher over the past year. These moves can change how you think about both upside and risk. Recent headlines have focused on Global Net Lease as part of broader discussions around US listed real estate investment...

Fate Therapeutics (FATE) opened 2026 with Q1 results showing revenue of about US$1.3 million and a basic EPS loss of US$0.26, alongside a net loss of US$31.2 million. Over recent quarters the company has seen quarterly revenue sit in a tight band around US$1.3 million to US$1.9 million, while basic EPS losses have moved between roughly US$0.26 and US$0.44 and trailing twelve month EPS has been around a US$1.09 loss. With the stock trading near US$1.90, the key question for investors is...

Avista (AVA) is drawing fresh attention after Avista Utilities started operating a community-based microgrid at Spokane’s Dr. Martin Luther King Jr. Family Outreach Center. The project combines solar, battery storage, and natural gas to support energy resilience. See our latest analysis for Avista. At a share price of $41.16, Avista has delivered a 6.30% year to date share price return, while the 1 year total shareholder return of 11.34% suggests interest has been building around its recent...

Enovix (ENVX) opened Q1 2026 with revenue of US$7.6 million and a basic EPS loss of US$0.18, alongside a net loss of US$38.26 million. On a trailing 12 month basis, the company generated US$34.32 million of revenue and a basic EPS loss of US$0.81 tied to a US$171.49 million net loss. Over recent quarters, the company has seen revenue range from US$5.10 million to US$11.27 million with quarterly basic EPS losses between US$0.12 and US$0.26. This provides a clear view of how growth and losses...

Akamai Technologies (NasdaqGS:AKAM) has agreed to acquire LayerX, a provider of browser-based AI usage control and secure enterprise browser technology. The deal extends Akamai’s Zero Trust portfolio into browser-level protection for generative AI applications used inside enterprises. The acquisition targets growing enterprise concerns around how employees access and use AI tools through their web browsers. Akamai Technologies, trading at $155.67, has seen strong recent share price...

Bullish (BLSH) opened 2026 with Q1 revenue of US$77.5 million, a basic EPS loss of US$3.85, and a net loss of US$581.7 million, setting a tough but clear baseline for investors watching how the story develops from here. Over the past year, the company has seen quarterly revenue move from US$39.3 million in Q4 2024 to US$77.5 million in Q1 2026, while EPS has swung between a profit of US$1.39 and losses such as US$3.85, highlighting how quickly margins can shift as the business scales. With...

Black Rock Coffee Bar (BRCB) opened Q1 2026 with revenue of US$55.5 million and basic EPS of US$0.02, alongside net income of US$0.4 million. These results put fresh numbers behind a company that has recently moved into profitability on a trailing twelve month basis. The company has seen quarterly revenue move from US$42.8 million in Q4 2024 to US$51.5 million in Q3 2025 and then US$53.6 million in Q4 2025. Trailing twelve month EPS shifted from a loss of US$0.33 in Q2 2025 to a small profit...

In the first quarter of 2026, monday.com reported revenue of US$351.27 million and net income of US$28.03 million, while also lifting its full‑year revenue outlook. Ahead of this earnings release, the company unveiled its largest product overhaul yet, rebranding as an AI Work Platform with native, configurable AI agents and a new consumption-based pricing model aimed at monetizing AI usage across its customer base. We’ll now examine how monday.com’s launch of its AI Work Platform and...

REGENXBIO (RGNX) Q1 2026 earnings snapshot REGENXBIO (RGNX) has just posted Q1 2026 results with revenue of US$6.4 million and a basic EPS loss of US$1.72, against a trailing twelve month basic EPS loss of US$5.59 on revenue of US$87.8 million. Over recent quarters the company has reported revenue of US$89.0 million in Q1 2025, followed by US$21.4 million in Q4 2024. Basic EPS moved from a profit of US$0.12 in Q1 2025 to a loss of US$1.01 in Q4 2024. These figures are likely to draw investor...

Leggett & Platt, Incorporated has reported past first-quarter 2026 results showing sales of US$918.2 million, down from US$1,022.1 million a year earlier, with net income falling from US$30.6 million to US$20 million. The simultaneous decline in both revenue and profitability gives investors a fresh data point on how the company is managing current demand conditions and cost pressures. We’ll now examine how this quarter’s weaker sales and earnings reshape Leggett & Platt’s investment...

Nebius Group (NasdaqGS:NBIS) has opened 2026 with Q1 revenue of US$399 million and Basic EPS of US$2.40, alongside net income of US$621.2 million, setting a clear marker after a volatile run of prior quarters. The company has seen revenue move from US$55.3 million in Q1 2025 and US$35.2 million in Q4 2024 to US$399 million in Q1 2026, with Basic EPS shifting from a loss of US$0.48 in Q1 2025 and a loss of US$0.58 in Q4 2024 to a profit of US$2.40. This puts the focus firmly on how sustainable...

Cooper Companies (NasdaqGS:COO) has appointed Paul Keel to its Board of Directors. Keel will also serve on the Board’s Audit Committee. The appointment brings experience from senior executive roles at major medical technology and industrial companies. For investors watching Cooper Companies at a share price of $60.38, this board change comes after a period of weak stock performance. The stock is down 15.7% over the past 30 days, 25.6% year to date, and 25.9% over the past year, with a 37.9%...

SS Innovations International (NasdaqCM:SSII) opened 2026 with Q1 revenue of about US$11.1 million and a basic EPS loss of US$0.02, while trailing 12 month figures show revenue of roughly US$48.5 million and a basic EPS loss of US$0.05. Over the past reported quarters, revenue has ranged from about US$5.1 million in Q1 2025 to US$14.5 million in Q4 2025, with basic EPS losses moving between roughly US$0.00 and US$0.03 per share. Investors are therefore likely to focus on how efficiently that...

Biohaven Ltd. reported first-quarter 2026 results in the past, narrowing its net loss to US$130.53 million from US$221.68 million a year earlier, while loss per share from continuing operations declined to US$0.88 from US$2.17. On the same day, Biohaven filed an omnibus shelf registration covering a wide range of securities, potentially giving the company considerable flexibility in how it may access capital in the future. With these earnings and the broad shelf registration in mind, we’ll...

In May 2026, Valpak Intelligence announced that its New Mover and New Business audience segments became directly available in LiveRamp’s Data Marketplace, giving marketers, brands, and agencies streamlined access to its postal-anchored identity data across major DSPs, SSPs, CTV platforms, and CRM destinations without separate licensing agreements. This partnership brings Valpak’s decades-built household identity spine, spanning approximately 135 million households and hundreds of millions of...

Keros Therapeutics (KROS) has just posted Q1 2026 results, with revenue of US$0.4 million, a basic EPS loss of US$1.21 and a net loss of US$23.7 million, setting the tone for the quarter at a share price of US$10.99. The company has seen quarterly revenue move from US$211.2 million in Q1 2025 to US$0.4 million in Q1 2026, while basic EPS shifted from a profit of US$3.66 to a loss of US$1.21. This puts the spotlight on how changes in revenue expectations and potential margin developments could...

In early May 2026, Vertex Pharmaceuticals filed a new US$2.87 billion shelf registration for 6,400,000 common shares tied to its employee stock ownership plan after closing several earlier ESOP-related shelf programs, alongside reporting first-quarter 2026 revenue of US$2,986.9 million and net income of US$1,031.4 million. At the same time, Vertex expanded access for its one-time CRISPR/Cas9 therapy CASGEVY through a reimbursement agreement with Germany’s GKV-Spitzenverband and reaffirmed...

Robotaxi expansion puts DiDi Global (DIDI.Y) in focus DiDi Global (DIDI.Y) is drawing attention after moving faster on autonomous driving, securing a road test license in Beijing for its latest robotaxi and preparing pilot programs in the UAE. See our latest analysis for DiDi Global. Despite the robotaxi progress, recent momentum has been weak. The share price is US$3.58 with a year to date share price return down 35.61%, while the 3 year total shareholder return is 12.23%, hinting at a mixed...

In recent days, Texas Instruments reported better-than-expected first-quarter results, highlighting strong analog revenue growth powered by industrial demand and a sharp rise in AI data center-related sales, while sector-wide optimism around semiconductors has been reinforced by broader index gains and supportive earnings across many chipmakers. At the same time, management’s emphasis on analog and embedded processing strengths, expanding internal manufacturing capacity, and upcoming...

Versant Media Group (VSNT) opened Q1 2026 with revenue of US$1.7 billion and basic EPS of US$1.99, setting the tone for how investors will weigh the latest move in profitability. Over recent periods the company has seen quarterly revenue move from US$1.7 billion in Q1 2025 to US$1.6 billion in Q4 2025 and then to US$1.7 billion in Q1 2026, while net income excluding extra items shifted from US$334.5 million to US$181 million and then to US$286 million, giving a clear read on how earnings...

Earlier this week, STERIS plc reported its fourth-quarter and fiscal 2026 results, with full-year sales of US$5,935.9 million and net income of US$782.3 million, alongside new fiscal 2027 guidance calling for 7%–8% reported revenue growth and a fresh US$1.00 billion share repurchase authorization. Management paired record annual revenue and earnings per share with plans for substantial buybacks and elevated capital spending, signaling confidence in the durability of demand for its infection...

Kulicke and Soffa Industries recently reported fiscal second-quarter 2026 results, with sales rising to US$242.62 million and net income improving to US$35.15 million, a shift from a net loss a year earlier. Alongside the earnings rebound, the company outlined plans to increase capital spending to expand thermo-compression bonding capacity for advanced packaging used in AI and high-performance chips. We’ll now examine how this earnings improvement and stepped-up thermo-compression investment...

Wolverine World Wide (WWW) opened Q1 2026 with revenue of US$457.6 million and basic EPS of US$0.25, against a current share price of US$15.22. This sets a clear marker for how its latest quarter feeds into a steadily building earnings profile. The company has seen quarterly revenue move from US$412.3 million and EPS of US$0.13 in Q1 2025 to US$457.6 million and EPS of US$0.25 in Q1 2026. Trailing twelve month EPS stands at US$1.24 on revenue of roughly US$1.9 billion, giving investors a...

Earlier this month, Rollins, Inc. held an Analyst/Investor Day where, according to RBC Capital Markets, the company was expected to reaffirm its 2026 and medium-term outlook, emphasizing its pricing approach and operational efficiency. Meanwhile, Orkin Canada, a Rollins subsidiary, highlighted seasonal carpenter ant risks and shared practical prevention guidance, underscoring how pest trends can support demand for the group’s services. We’ll now examine how Rollins’ confidence in its...